Z Gastroenterol 2013; 51(7): 638-642
DOI: 10.1055/s-0033-1335326
Kasuistik
© Georg Thieme Verlag KG Stuttgart · New York

Clinical Features of Eosinophilic Gastroenteritis with Ascites

Klinische Präsentation der eosinophilen Gastritis mit Aszites
L. Liu
1   Gastroenterology, Nanhai Hospital, Southern Medical University, Foshan
,
X. Y. Liang
1   Gastroenterology, Nanhai Hospital, Southern Medical University, Foshan
,
H. He
2   Obstetrics and Gynecology, Nanhai Hospital, Southern Medical University, Foshan
,
H. Huang
1   Gastroenterology, Nanhai Hospital, Southern Medical University, Foshan
,
L. P. Jia
1   Gastroenterology, Nanhai Hospital, Southern Medical University, Foshan
› Author Affiliations
Further Information

Publication History

13 November 2012

16 March 2013

Publication Date:
09 July 2013 (online)

Abstract

Objective: The aim of this study was to evaluate the clinical features and treatment responses of eosinophilic gastroenteritis (EG) with ascites.

Methods: Clinical data were collected on 6 EG patients with ascites from 2000 to 2012.

Results: Six patients were included in this study, ranging in age from 15 to 30 years. Most had an acute onset (5/6). The clinical manifestations included abdominal pain (5/6), vomiting (4/6), and diarrhea (3/6). The absolute values and percentages of peripheral blood eosinophils (Eos) were significantly elevated in all patients. Erosive or ulcerative lesions were found on endoscopic examination of all patients (6/6). Eosinophilic inflitration was confirmed by endoscopic biopsies (4/6). Ultrasound or abdominal CT showed gastrointestinal wall thickening and peritoneal effusion (6/6). Ascites from the patients were analyzed. Eos were found in ascites by pathological examination in the majority (5/6). The symptoms and peripheral eosinophilia responded to glucocorticoid treatment (p < 0.05). All the patients had good outcomes. One female patient had a relapse, which responded to re-administration of glucocorticoid treatment.

Conclusions: EG with ascites is more common in young patients, often presenting with non-specific symptoms. Typical clinical manifestations include acute onset, abdominal pain, and ascites. Eos in ascites and peripheral blood are the main diagnostic clues. Ultrasound and CT examinations are important to support the diagnosis of EG, and endoscopic biopsies can help to establish the diagnosis. Treatment with glucocorticoids is effective.

Zusammenfassung

Ziel: Evaluierung der klinischen Präsentation und Behandlungsergebnisse bei eosinophiler Gastroenteritis (EG) mit begleitendem Aszites.

Methoden: Von 2000 bis 2012 wurden klinische Daten von 6 EG-Patienten mit Aszites gesammelt.

Ergebnisse: Sechs Patienten im Alter von 15 - 30 Jahren wurden in die Studie eingeschlossen. Bei den meisten Patienten (5/6) traten die Symptome akut auf. Klinisch manifestierten sich abdominelle Schmerzen (5/6), Erbrechen (4/6), und Diarrhöe (3/6). Bei allen Patienten waren die absoluten und prozentualen Werte der peripheren Eosinophilen in Blut (Eos) signifikant erhöht. Die endoskopische Untersuchung ergab bei allen Patienten (6/6) erosive oder ulzerative Läsionen. Die endoskopische Biopsie bestätigte die Infiltration mit Eosinophilen (4/6). Eine Sonografie oder CT des Abdomens zeigte eine Wandverdickung im Magen-Darm-Trakt und peritoneale Flüssigkeitsansammlungen (6/6). Aszites der Patienten wurde untersucht. Die pathologische Untersuchung zeigte bei der Mehrheit der Patienten (5/6) das Vorhandensein von Eosinophilen. Die klinischen Symptome sowie die periphere Eosinophilie sprachen auf die Behandlung mit Glukokortikoiden an (p < 0,05). Alle Patienten zeigten ein gutes Behandlungsergebnis. Eine Patientin erlitt einen Rückfall, der jedoch auf erneute Gabe von Glukokortikoiden ansprach.

Schlussfolgerungen: EG mit Aszites tritt bei jungen Patienten häufiger auf, oft mit unspezifischen Symptomen. Typische klinische Manifestationen sind akutes Auftreten der Symptome, abdominelle Schmerzen und Aszites. Das Vorhandensein von Eosinophilen in Aszites und peripherem Blut sind die wesentlichen dignostischen Hinweise. Sonografie und CT Untersuchungen sind wichtig, um die Diagnose der EG zu stützen und eine endoskopische Biopsie kann bei der Diagnosestellung hilfreich sein. Die Behandlung mit Glukokortikoiden hat sich als wirksam erwiesen.

 
  • References

  • 1 Baig MA, Qadir A, Rasheed J. A review of eosinophilic gastroenteritis. J Natl Med Assoc 2006; 98: 1616-1619
  • 2 Klein NC, Hargrove RL, Sleisenger MH et al. Eosinophilic gastroenteritis. Medicine (Baltimore) 1970; 49: 299-319
  • 3 Zhou HB, Chen JM, Du Q. Eosinophilic gastroenteritis with ascites and hepatic dysfunction. World J Gastroenterol 2007; 13: 1303-1305
  • 4 Fenoglio LM, Benedetti V, Rossi C et al. Eosinophilic gastroenteritis with ascites: a case report and review of the literature. Dig Dis Sci 2003; 48: 1013-1020
  • 5 Harmon WA, Helman CA. Eosinophilic gastroenteritis and ascites. J Clin Gastroenterol 1981; 3: 371-373
  • 6 Talley NJ, Shorter RG, Phillips SF et al. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990; 31: 54-58
  • 7 Oyaizu N, Uemura Y, Izumi H et al. Eosinophilic gastroenteritis. Immunohistochemical evidence for IgE mast cell-mediated allergy. Acta Pathol Jpn 1985; 35: 759-766
  • 8 Von Wattenwyl F, Zimmermann A, Netzer P. Synchronous first manifestation of an idiopathic eosinophilic gastroenteritis and bronchial asthma. Eur J Gastroenterol Hepatol 2001; 13: 721-725
  • 9 Freeman HJ. Longstanding eosinophilic gastroenteritis of more than 20 years. Can J Gastroenterol 2009; 23: 632-634
  • 10 Kalantar SJ, Marks R, Lambert JR et al. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci 1997; 42: 2327-2332
  • 11 Lee J, Dierkhising R, Wu TT et al. Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic. Dig Dis Sci 2011; 56: 3254-3261
  • 12 Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004; 113: 11-28
  • 13 Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009; 58: 721-732
  • 14 Deslandres C, Russo P, Gould P et al. Perforated duodenal ulcer in a pediatric patient with eosinophilic gastroenteritis. Can J Gastroenterol 1997; 11: 208-212
  • 15 Katz AJ, Goldman H, Grand RJ. Gastric mucosal biopsy in eosinophilic (allergic) gastroenteritis. Gastroenterology 1977; 73: 705-709
  • 16 Tien FM, Wu JF, Jeng YM et al. Clinical features and treatment responses of children with eosinophilic gastroenteritis. Pediatr Neonatol 2011; 52: 272-278
  • 17 Murata A, Akahoshi K, Kouzaki S et al. Eosinophilic gastroenteritis observed by double balloon enteroscopy and endoscopic ultrasonography in the whole gastrointestinal tract. Acta Gastroenterol Belg 2008; 71: 418-422
  • 18 Alnaser S, Aljebreen AM. Endoscopic ultrasound and hisopathologic correlates in eosinophilic gastroenteritis. Saudi J Gastroenterol 2007; 13: 91-94
  • 19 Horton KM, Corl FM, Fishman EK. CT of nonneoplastic diseases of the small bowel: spectrum of disease. J Comput Assist Tomogr 1999; 23: 417-428
  • 20 Savino A, Salvatore R, Cafarotti A et al. Role of ultrasonography in the diagnosis and follow-up of pediatric eosinophilic gastroenteritis: a case report and review of the literature. Ultraschall Med 2011; 32: 57-62
  • 21 Zhang L, Duan L, Ding S et al. Eosinophilic gastroenteritis: clinical manifestations and morphological characteristics, a retrospective study of 42 patients. Scand J Gastroenterol 2011; 46: 1074-1080
  • 22 Kelly HW, Van Natta ML, Covar RA et al. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008; 122: 53-61
  • 23 Pérez-Millán A, Martín-Lorente JL, López-Morante A et al. Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci 1997; 42: 342-344
  • 24 Urek MC, Kujundzić M, Banić M et al. Leukotriene receptor antagonists as potential steroid sparing agents in a patient with serosal eosinophilic gastroenteritis. Gut 2006; 55: 1363-1364
  • 25 De Maeyer N, Kochuyt AM, Van Moerkercke W et al. Montelukast as a treatment modality for eosinophilic gastroenteritis. Acta Gastroenterol Belg 2011; 74: 570-575